Aurora Cannabis Inc's stock has had a mixed performance lately, showing a notable decline over the past month despite some positive financial announcements.
Aurora Cannabis Inc (ACB.TO) closed at C$3.77, reflecting a 0.78% increase today but a 5.62% decline over the past week. This comes after recent fiscal results that highlighted significant growth in revenue, especially in international markets.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$237.24M
52W high
$9.33
52W low
$3.74
1W change
-5.62%
Beta
1.35
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 51.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.84
+51.3% Upside
Current Price
C$3.86
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
41.0%
Annualized
90-Day Vol
48.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.23
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.64 | C$3.16 โ C$4.19 |
| 60 trading days | C$3.43 | C$2.81 โ C$4.18 |
| 90 trading days | C$3.23 | C$2.53 โ C$4.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While Aurora Cannabis's recent earnings reports show revenue growth and positive cash flow, the stock's overall downward trend raises questions about the sustainability of this momentum given the broader market conditions.
Aurora Cannabis Reports 37% Increase in Medical Cannabis Revenue Year-Over-Year
The company achieved a global medical cannabis net revenue of $64.8 million in its latest report, showcasing strong growth in a competitive industry.
Bull case
Aurora Cannabis has reported impressive increases in both global and international medical cannabis net revenue, along with a strong balance sheet that carries no debt. This positions the company well for future growth as the cannabis sector continues to expand.
Bear case
Despite the recent revenue growth, the stock has significantly underperformed year-to-date, down 35.02%. Concerns about profitability, indicated by a negative profit margin and earnings per share (EPS), may deter investors.
Recent Price Action
Aurora Cannabis Inc closed at C$3.77, marking a 0.78% increase today. However, the stock has faced a challenging week, declining 5.62% and dropping 15.90% over the past month. Year-to-date, the stock is down 35.02%, indicating a significant downturn amidst fluctuating market conditions.
Company News and Financial Results
Aurora Cannabis recently announced its fiscal 2026 first quarter results, showcasing a 37% increase in global medical cannabis net revenue, which reached $64.8 million. Notably, international medical cannabis revenue surged by 85% to $37.1 million. Adjusted EBITDA grew over 200% to $10.8 million, with positive free cash flow of $9.2 million. The company maintains a strong balance sheet, boasting approximately $186 million in cash and a debt-free status.
Technical Picture
From a technical standpoint, Aurora Cannabis is currently trading below its 50-day moving average of C$4.47 and its 200-day moving average of C$5.56, indicating a bearish trend. The stock has a 52-week range of C$3.74 to C$9.33, with the current price sitting just 1% above its 52-week low. The beta of 1.35 suggests higher volatility compared to the market. Recent trading volume was recorded at 330,321 shares, which is 0.59 times the 20-day average volume of 440,172 shares, indicating lower trading activity.
Insider Activity
Currently, there are no significant insider trading activities reported for Aurora Cannabis, which can be an important indicator of internal confidence in the company's future prospects.
Price Action Summary
Aurora Cannabis Inc closed at C$3.77, reflecting a 0.78% increase today, but the stock remains under pressure with a 5.62% decline over the past week. Investors will be watching closely for any further developments that may impact the company's performance.
Advertisement
